UNICYCIVE THERAPEUTICS INC (UNCY) Stock Analyst Earnings Estimates
NASDAQ:UNCY - Nasdaq - US90466Y1038 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 950K | 675K -28.95% | -100.00% | 33.146M | 327.72M 888.72% | 612.55M 86.91% | 399.6M -34.76% | 412.16M 3.14% | 539.12M 30.80% | 339.23M -37.08% | 410.81M 21.10% | ||
| EBITDA YoY % growth | -8.98M | -18.04M -100.89% | -20.765M -15.11% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -8.98M -344.55% | -18.05M -101.00% | -20.774M -15.09% | -30.664M -47.61% | -37.409M -22.00% | 199.62M 633.61% | 394.56M 97.66% | 237.99M -39.68% | 250.02M 5.05% | 303.83M 21.52% | 171.78M -43.46% | 217.2M 26.44% | |
| Operating Margin | N/A | -1,900.00% | -3,077.63% | N/A | -112.86% | 60.91% | 64.41% | 59.56% | 60.66% | 56.36% | 50.64% | 52.87% | |
| EPS YoY % growth | N/A | -1.20 -58.27% | -1.61 -34.17% | -0.51 68.07% | -0.21 58.99% | 1.02 585.07% | 1.60 56.41% | 0.84 -47.23% | 0.84 -0.91% | 0.90 7.72% | 0.78 -13.39% | 1.00 28.10% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.09 58.27% | -0.13 78.26% | -0.14 3.44% | -0.04 14.32% | -0.01 93.33% | -0.02 84.62% | 0.47 423.94% | 0.65 1,623.81% | 0.62 10,266.67% |
| Revenue Q2Q % growth | 10.696M | 20.92M | 21.094M | 105.48M | 168.76M 1,477.79% | 212.27M 914.67% | |||
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -7.365M -16.67% | -8.996M 2.27% | -10.059M -35.91% | -10.311M -64.96% | -10.1M -37.13% | -1.997M 77.80% | 56.833M 665.01% | 100.89M 1,078.43% | 131.11M 1,398.15% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -0.05 61.54% | -0.15 | 0.10 | 67.68% |
| Q2 2024 Q2Q % growth | -0.15 48.28% | -0.20 | 0.05 | 23.27% |
| Q1 2024 Q2Q % growth | -0.61 37.11% | -0.16 | -0.45 | -285.83% |
| Q4 2023 Q2Q % growth | -0.22 37.14% | -0.17 | -0.05 | -28.77% |
| Q3 2023 Q2Q % growth | -0.13 64.86% | -0.12 | -0.01 | -6.21% |
| Q2 2023 Q2Q % growth | -0.29 -20.83% | -0.35 | 0.06 | 16.38% |
| Q1 2023 Q2Q % growth | -0.97 -304.17% | -0.38 | -0.59 | -155.30% |
| Q4 2022 Q2Q % growth | -0.35 -45.83% | -0.25 | -0.10 | -40.63% |
| Q3 2022 Q2Q % growth | -0.37 -362.50% | -0.29 | -0.08 | -29.55% |
| Q2 2022 Q2Q % growth | -0.24 -84.62% | -0.23 | -0.01 | -3.80% |
| Q1 2022 Q2Q % growth | -0.24 | -0.17 | -0.07 | -42.60% |
| Q4 2021 Q2Q % growth | -0.24 | -0.14 | -0.10 | -74.29% |
| Q3 2021 Q2Q % growth | -0.08 | -0.11 | 0.03 | 25.30% |
| Q2 2021 Q2Q % growth | -0.13 | -0.11 | -0.02 | -15.86% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2024 Q2Q % growth | -100.00% | % | ||
| Q3 2023 Q2Q % growth | -100.00% | % | ||
| Q1 2023 Q2Q % growth | 675K | 382.5K | 292.5K | 76.47% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 37.5% | 35.71% | 8.36% | 30.96% |
| Revenue | N/A | N/A | N/A | N/A |